Search Within

Guido Dalbagni

  1. "Hematology-Oncology Fellows"
Formats
  1. Meeting Abstract (10)
  2. Journal Article (9)
  3. Editorial (1)
Groups
  1. Department of Medicine (20)
  2. Hematology-Oncology Fellows (20)
  3. Surgery (20)
  4. Urology (20)
  5. Genitourinary Oncology Service (19)
  6. Solid Tumor Oncology Division (19)

More Groups

People
  1. Bernard Bochner (19)
  2. Jonathan Rosenberg (18)
  3. Gopakumar Iyer (17)
  4. Dean Bajorin (16)
  5. Hikmat Al-Ahmadie (16)
  6. Samuel Funt (16)

More People

Years
  1. 2025 (2)
  2. 2024 (1)
  3. 2023 (1)
  4. 2022 (3)
  5. 2021 (2)
  6. 2020 (4)

More Years

Publications
  1. Journal of Clinical Oncology (8)
  2. European Urology (2)
  3. JCO Precision Oncology (2)
  4. American Journal of Surgical Pathology (1)
  5. British Journal of Cancer (1)
  6. Clinical Cancer Research (1)

More Publications

Publishers
  1. American Society of Clinical Oncology (10)
  2. Elsevier Inc. (2)
  3. Elsevier Science, Inc. (2)
  4. American Association for Cancer Research (1)
  5. Frontiers Media S.A. (1)
  6. Lippincott Williams & Wilkins (1)

More Publishers

Results (20)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Correlative science from a phase I study of intravesical Fc-optimized anti-CD40 agonist antibody 2141-V11 for non-muscle invasive bladder cancer (NMIBC) unresponsive to bacillus calmette-guerin (BCG)
    Meeting Abstract

    Bochner, B. H.; Alam, S. M.; Blanchard, L.; Yao, N.; Angulo-Lozano, J.; Wong, J.; Knorr, D.; Whiting, K.; Seshan, V.; Donahue, T.; more...
    Urologic Oncology: Seminars and Original Investigations (2025)

    Fulltext@MSK | Save
  • Case report: Clinical and molecular features of renal gastrointestinal tumor
    Journal Article

    Makker, S.; Rammal, R.; Gu, P.; Dalbagni, G.; Al-Ahmadie, H.; Agaram, N. P.; Iyer, G.; Kotecha, R. R.
    Frontiers in Oncology (2025)

    Fulltext@MSK | Save
  • Natural history and genomic landscape of chemotherapy-resistant muscle-invasive bladder cancer
    Journal Article

    Lenis, A. T.; Whiting, K.; Ravichandran, V.; Tallman, J. E.; Alam, S. M.; Chu, C. E.; De Jesus Escano, M.; Bochner, E.; Katims, A.; Reisz, P. A.; more...
    JCO Precision Oncology (2024)

    Fulltext@MSK | Save
  • Neoadjuvant nivolumab (N) + ipilimumab (I) in cisplatin-ineligible patients with upper tract urothelial cancer (UTUC)
    Meeting Abstract

    Teo, M. Y.; Guercio, B. J.; Pietzak, E. J.; Ponomarev, M.; Regazzi, A. M.; Quinlan, C.; Aggen, D. H.; Donahue, T. F.; Goh, A. C.; Cha, E. K.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • Clinical and genomic characterization of bladder carcinomas with glandular phenotype
    Journal Article

    Almassi, N.; Whiting, K.; Toubaji, A.; Lenis, A. T.; Jordan, E. J.; Won, H.; Regazzi, A. M.; Chen, Y. B.; Gopalan, A.; Sirintrapun, S. J.; more...
    JCO Precision Oncology (2022)

    Fulltext@MSK | Save
  • Phase I study of intravesical anti-CD40 agonist antibody 2141-V11 for non-muscle invasive bladder cancer unresponsive to Bacillus Calmette-Guerin (BCG) therapy
    Meeting Abstract

    Wong, J. L.; Knorr, D.; Whiting, K.; Seshan, V. E.; Pietzak, E. J.; Donahue, T. F.; Cha, E. K.; Goh, A. C.; Smith, R.; Dalbagni, G.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Long-term outcomes of local and metastatic small cell carcinoma of the urinary bladder and genomic analysis of patients treated with neoadjuvant chemotherapy
    Journal Article

    Teo, M. Y.; Guercio, B. J.; Arora, A.; Hao, X.; Regazzi, A. M.; Donahue, T.; Herr, H. W.; Goh, A. C.; Cha, E. K.; Pietzak, E.; more...
    Clinical Genitourinary Cancer (2022)

    Fulltext@MSK | Save
  • Large cell neuroendocrine carcinoma of the urothelial tract (LNEC): The MSKCC experience
    Meeting Abstract

    Guercio, B. J.; Gandhi, J.; Teo, M. Y.; Lattanzi, M.; Funt, S. A.; Aggen, D. H.; Chen, Y. B.; Fine, S.; Pietzak, E. J.; Bochner, B. H.; more...
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save
  • Natural history, response to systemic therapy, and genomic landscape of plasmacytoid urothelial carcinoma
    Journal Article

    Teo, M. Y.; Al-Ahmadie, H.; Seier, K.; Tully, C.; Regazzi, A. M.; Pietzak, E.; Solit, D. B.; Tickoo, S.; Reuter, V.; Cha, E. K.; more...
    British Journal of Cancer (2021)

    Fulltext@MSK | Save
  • Fibroblast growth factor receptor 3 alteration status is associated with differential sensitivity to platinum-based chemotherapy in locally advanced and metastatic urothelial carcinoma
    Journal Article

    Teo, M. Y.; Mota, J. M.; Whiting, K. A.; Li, H. A.; Funt, S. A.; Lee, C. H.; Solit, D. B.; Al-Ahmadie, H.; Milowsky, M. I.; Balar, A. V.; more...
    European Urology (2020)

    Fulltext@MSK | Save